Back

A novel integrative risk scoring system for predicting atrial fibrillation in breast cancer patients: a multicenter cohort study

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation prediction and risk stratification Prevalence and Incidence of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Do Young Kim

Ajou University Hospital, Suwon (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Polygenic risk and echocardiographic markers of left atrial dysfunction improve prediction of incident atrial fibrillation: insights from the akershus cardiac examination (ACE) 1950 Study
Doctor M. Solberg (Gjettum, NO)
Abstract
Presentation thumbnail
Body mass index, weight change, and long-term risk of incident atrial fibrillation in a nationwide cohort
Miss Y. Elhayani (Beer Sheva, IL)
Abstract
Presentation thumbnail
Polygenic risk stratifies atrial fibrillation into biologically distinct prognostic phenotypes
Ms E. Ghanbari (Berlin, DE)
Abstract
Presentation thumbnail
Glycemic control and atrial fibrillation: baseline HbA1c predicts risk, early HbA1c change does not
Miss Y. Elhayani (Beer Sheva, IL)
Abstract
Presentation thumbnail
Multimodal prediction of atrial fibrillation following cardiac surgery using clinical and polygenic scores
Doctor G. Jabbour (Montreal, CA)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation prediction and risk stratification

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Evaluating the clinical consequences of atrial fibrillation in asian women with breast cancer
21 June 2025
thumbnail
Congress Presentation
Integrating Strain Imaging into the HFA-ICOS Risk Score: the SICOS score.
21 June 2025
thumbnail
Congress Presentation
Paroxysmal atrial fibrillation prediction score based on 24-hours electrocardiogram-monitoring data
4 April 2025
thumbnail
Congress Presentation
Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors
5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources